141 related articles for article (PubMed ID: 16979789)
1. Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells.
Hou X; Wei L; Harada A; Tatamoto K
Lung Cancer; 2006 Nov; 54(2):143-8. PubMed ID: 16979789
[TBL] [Abstract][Full Text] [Related]
2. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
3. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
Ryan RR; Weber HC; Mantey SA; Hou W; Hilburger ME; Pradhan TK; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1998 Oct; 287(1):366-80. PubMed ID: 9765358
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
[TBL] [Abstract][Full Text] [Related]
6. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
[TBL] [Abstract][Full Text] [Related]
8. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
[TBL] [Abstract][Full Text] [Related]
10. [Des-Met14]bombesin analogues function as small cell lung cancer bombesin receptor antagonists.
Staley J; Coy D; Taylor JE; Kim S; Moody TW
Peptides; 1991; 12(1):145-9. PubMed ID: 1646997
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
[TBL] [Abstract][Full Text] [Related]
12. Two bombesin analogues discriminate between neuromedin B- and bombesin-induced calcium flux in a lung cancer cell line.
Ryan RR; Daniel JL; Cowan A
Peptides; 1993; 14(6):1231-5. PubMed ID: 8134305
[TBL] [Abstract][Full Text] [Related]
13. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
14. A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.
Moreno P; Mantey SA; Lee SH; Ramos-Álvarez I; Moody TW; Jensen RT
Peptides; 2018 Mar; 101():213-226. PubMed ID: 29410320
[TBL] [Abstract][Full Text] [Related]
15. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
Mantey SA; Coy DH; Entsuah LK; Jensen RT
J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
[TBL] [Abstract][Full Text] [Related]
16. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
17. Bombesin receptor structure and expression in human lung carcinoma cell lines.
Fathi Z; Way JW; Corjay MH; Viallet J; Sausville EA; Battey JF
J Cell Biochem Suppl; 1996; 24():237-46. PubMed ID: 8806106
[TBL] [Abstract][Full Text] [Related]
18. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells.
Fathi Z; Corjay MH; Shapira H; Wada E; Benya R; Jensen R; Viallet J; Sausville EA; Battey JF
J Biol Chem; 1993 Mar; 268(8):5979-84. PubMed ID: 8383682
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells.
Toi-Scott M; Jones CL; Kane MA
Lung Cancer; 1996 Nov; 15(3):341-54. PubMed ID: 8959679
[TBL] [Abstract][Full Text] [Related]
20. Effect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes.
González N; Martín-Duce A; Martínez-Arrieta F; Moreno-Villegas Z; Portal-Núñez S; Sanz R; Egido J
Int J Mol Med; 2015 Apr; 35(4):925-31. PubMed ID: 25653074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
